Guidance for industry : use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2009]
Subjects:	Trypanosoma cruzi > United States > Prevention. Blood > Transfusion > Government policy > United States. Cell transplantation > Government policy > United States. Transplantation of organs, tissues, etc. > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113497

Available Online